Zobrazeno 1 - 10
of 44
pro vyhledávání: '"J. S. Franzone"'
Autor:
Annagiulia Gramenzi, Claudio Zavaglia, Indira Rezakovic, J. S. Franzone, G Ideo, Mauro Bernardi, E Altomare, Giovanni Gasbarrini, R. Severini, Pietro Andreone, Carmela Cursaro, O Albano
Publikováno v:
Hepatology. 24:774-777
It has recently been shown that thymosin-alpha1(T-alpha1), a synthetic polypeptide of thymic origin, is able to promote disease remission and inhibition of hepatitis B virus (HBV) replication in patients affected by hepatitis B e antigen (HBeAg)-posi
Autor:
C, Zavaglia, R, Severini, C, Tinelli, J S, Franzone, A, Airoldi, S, Tempini, G, Bettale, G, Ideo
Publikováno v:
Digestive diseases and sciences. 45(4)
No consistently effective therapy is yet available for the treatment of chronic HBsAg, anti-HBe, HBV-DNA-positive hepatitis. A multicenter trial has shown that the response rates are not significantly different when patients with anti-HBe-positive he
Publikováno v:
Methods and findings in experimental and clinical pharmacology. 13(4)
beta-HET (beta-Hydroxyethyltheophylline), the major metabolite of the antibronchospastic, antiasthmatic drug doxofylline was studied in several in vitro and in vivo trials to characterize its pharmaco-toxicological profile. When compared to the paren
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals. 19(2)
The metabolic transformation of the antibronchospastic compound ABC-99 [7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine] was studied in vitro with a rat liver microsomal preparation containing an NADPH-generating system. Thirty percent of the ABC-9
Publikováno v:
International journal of tissue reactions. 13(3)
This paper contributes to the pharmacological profile of doxofylline (Ansimar), a new xanthine derivative with high antibronchospastic activity and no extrapulmonary or cardiac side-effects, clearly demonstrating its inability to mobilize intracellul
Publikováno v:
Arzneimittel-Forschung. 40(9)
Iron lysozyme glutarate (ABC 1020) is a new soluble complex with an anti-anaemic activity superior to that of ferritin, ferrous sulphate and iron succinyl protein. Iron serum concentrations after treatment with ABC 1020 are higher than after ferritin
Publikováno v:
ChemInform. 21
Autor:
M C, Reboani, J S, Franzone
Publikováno v:
Drugs under experimental and clinical research. 16(6)
A new methylxanthine derivative [7-(1,3-dithiolan-2-ylmethyl)-1,3-dimethylxanthine, ABC 99] with mucoregulatory and antibronchospastic properties has been studied. ABC 99 was observed to have marked anti-inflammatory activity in a series of experimen
Publikováno v:
Drugs under experimental and clinical research. 16(6)
The kinetics (absorption, tissue distribution and excretion) of 7-(1,3-dithiolan-2-ylmethyl)-1, 3-dimethylxanthine(ABC 99) were studied in the rat. ABC 99 was administered orally at doses of 10, 30 and 100 mg/kg for the serum kinetic studies. Only th
Publikováno v:
Drugs under experimental and clinical research. 16(6)
7-(1,3-Dithiolan-2-ylmethyl)-1,3-dimethylxanthine (ABC 99) has been studied in the animal to evaluate its pharmacological activity. This compound was found to have antibronchospastic activity in vitro and in vivo markedly greater than aminophylline.